FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Removes Recommended Pause in Use and Approves Required Updated Labeling: FDA Safety Communication
Similar Posts
Darmerica, LLC – 716152 – 12/08/2025
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/MisbrandedRhino Gummy Royal 50000 may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Rhino Gummy Royal 50000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.FDA and Kratom
Kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive in conventional food.GDUFA Type II API DMF Payment Receipts Report
GDUFA Type II API DMF Payment Receipts ReportFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical. Los Angeles, CA. Amended 483 issued 12/20/2019
Task Description Request Please post to the ORA Electronic Reading Room
Record Date 12/20/2019
Short Title (70 char) Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical. Los Angeles, CA. Amended 483 issued 12/20/2019
FEI Number 3013341563
Firm Name Fusion IV Pharmaceuticals, Inc.
Record Type AmeWhat is a Medical Device Recall?
What is a Medical Device Recall?